R M Ridley|H F Baker - JoVE Visualize

Showing results (101-110 of 113) with videos related to

Pageof 12

Sort By:

Stroke|January 4, 2001

NXY-059, a free radical--trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate speciesJ W Marshall, K J Duffin, A R Green, et al.

Journal of Medical Genetics|April 1, 1991

Patterns of inheritance of the symptoms of Huntington's disease suggestive of an effect of genomic imprintingR M Ridley, C D Frith, L A Farrer, et al.

American Journal of Human Genetics|March 1, 1992

A test of the hypothesis that age at onset in Huntington disease is controlled by an X-linked recessive modifierR M Ridley, L A Farrer, C D Frith, et al.

British Journal of Pharmacology|December 10, 1998

Learning impairments induced by glutamate blockade using dizocilpine (MK-801) in monkeysJ A Harder, A A Aboobaker, T C Hodgetts, et al.

Journal of Medical Genetics|September 1, 1988

Anticipation in Huntington's disease is inherited through the male line but may originate in the femaleR M Ridley, C D Frith, T J Crow, et al.

Psychopharmacology|October 1, 1996

The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmosetJ A Harder, C J Maclean, J T Alder, et al.

Psychological Medicine|February 1, 1977

Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patientsM H Joseph, F Owen, H F Baker, et al.

Psychopharmacology|June 28, 1979

3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixolM H Joseph, H F Baker, E C Johnstone, et al.

Psychopharmacology|December 21, 1976

Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patientsM H Joseph, H F Baker, E C Johnstone, et al.

Psychopharmacology|April 25, 1979

Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjectsM H Jospeh, H F Baker, T J Crow, et al.

Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:

Pageof 12

Stroke|January 4, 2001

NXY-059, a free radical--trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate speciesJ W Marshall, K J Duffin, A R Green, et al.

Journal of Medical Genetics|April 1, 1991

Patterns of inheritance of the symptoms of Huntington's disease suggestive of an effect of genomic imprintingR M Ridley, C D Frith, L A Farrer, et al.

American Journal of Human Genetics|March 1, 1992

A test of the hypothesis that age at onset in Huntington disease is controlled by an X-linked recessive modifierR M Ridley, L A Farrer, C D Frith, et al.

British Journal of Pharmacology|December 10, 1998

Learning impairments induced by glutamate blockade using dizocilpine (MK-801) in monkeysJ A Harder, A A Aboobaker, T C Hodgetts, et al.

Journal of Medical Genetics|September 1, 1988

Anticipation in Huntington's disease is inherited through the male line but may originate in the femaleR M Ridley, C D Frith, T J Crow, et al.

Psychopharmacology|October 1, 1996

The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmosetJ A Harder, C J Maclean, J T Alder, et al.

Psychological Medicine|February 1, 1977

Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patientsM H Joseph, F Owen, H F Baker, et al.

Psychopharmacology|June 28, 1979

3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixolM H Joseph, H F Baker, E C Johnstone, et al.

Psychopharmacology|December 21, 1976

Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patientsM H Joseph, H F Baker, E C Johnstone, et al.

Psychopharmacology|April 25, 1979

Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjectsM H Jospeh, H F Baker, T J Crow, et al.

Pageof 12